Acute renal failure after treatment with sunitinib in a patient with multiple myeloma

Nelson Leung; Nathan A. Saucier; Steven R. Zeldenrust; Heidi D. Gunderson; Lynn D. Cornell

doi:10.1093/ndtplus/sfp037

Acute renal failure after treatment with sunitinib in a patient with multiple myeloma

Nelson Leung
, Nathan A. Saucier
, Steven R. Zeldenrust
, Heidi D. Gunderson
, Lynn D. Cornell

Laboratory Medicine and Pathology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Sunitinib is a multiple tyrosine kinase receptors inhibitor that is approved for the treatment of advanced renal cell carcinoma. Amongst its targets are fetal liver tyrosine kinase receptor 3 (FLT 3) and vascular endothelial growth factor receptor (VEGFR). Renal toxicity has not been reported from the trials, but several patients have been reported to develop a pre-eclampsia-like syndrome. We report the first case of acute tubular necrosis in a patient with multiple myeloma following treatment with sunitinib.

Original language	English (US)
Pages (from-to)	292-294
Number of pages	3
Journal	NDT Plus
Volume	2
Issue number	4
DOIs	https://doi.org/10.1093/ndtplus/sfp037
State	Published - Aug 2009

Keywords

acute renal failure
drug toxicity
sunitinib

ASJC Scopus subject areas

Nephrology
Transplantation

Access to Document

10.1093/ndtplus/sfp037

Cite this

@article{8c50fdeb1bb54fddbe58326674f12053,

title = "Acute renal failure after treatment with sunitinib in a patient with multiple myeloma",

abstract = "Sunitinib is a multiple tyrosine kinase receptors inhibitor that is approved for the treatment of advanced renal cell carcinoma. Amongst its targets are fetal liver tyrosine kinase receptor 3 (FLT 3) and vascular endothelial growth factor receptor (VEGFR). Renal toxicity has not been reported from the trials, but several patients have been reported to develop a pre-eclampsia-like syndrome. We report the first case of acute tubular necrosis in a patient with multiple myeloma following treatment with sunitinib.",

keywords = "acute renal failure, drug toxicity, sunitinib",

author = "Nelson Leung and Saucier, \{Nathan A.\} and Zeldenrust, \{Steven R.\} and Gunderson, \{Heidi D.\} and Cornell, \{Lynn D.\}",

year = "2009",

month = aug,

doi = "10.1093/ndtplus/sfp037",

language = "English (US)",

volume = "2",

pages = "292--294",

journal = "NDT Plus",

issn = "1753-0784",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Acute renal failure after treatment with sunitinib in a patient with multiple myeloma

AU - Leung, Nelson

AU - Saucier, Nathan A.

AU - Zeldenrust, Steven R.

AU - Gunderson, Heidi D.

AU - Cornell, Lynn D.

PY - 2009/8

Y1 - 2009/8

N2 - Sunitinib is a multiple tyrosine kinase receptors inhibitor that is approved for the treatment of advanced renal cell carcinoma. Amongst its targets are fetal liver tyrosine kinase receptor 3 (FLT 3) and vascular endothelial growth factor receptor (VEGFR). Renal toxicity has not been reported from the trials, but several patients have been reported to develop a pre-eclampsia-like syndrome. We report the first case of acute tubular necrosis in a patient with multiple myeloma following treatment with sunitinib.

AB - Sunitinib is a multiple tyrosine kinase receptors inhibitor that is approved for the treatment of advanced renal cell carcinoma. Amongst its targets are fetal liver tyrosine kinase receptor 3 (FLT 3) and vascular endothelial growth factor receptor (VEGFR). Renal toxicity has not been reported from the trials, but several patients have been reported to develop a pre-eclampsia-like syndrome. We report the first case of acute tubular necrosis in a patient with multiple myeloma following treatment with sunitinib.

KW - acute renal failure

KW - drug toxicity

KW - sunitinib

UR - https://www.scopus.com/pages/publications/77955973922

UR - https://www.scopus.com/pages/publications/77955973922#tab=citedBy

U2 - 10.1093/ndtplus/sfp037

DO - 10.1093/ndtplus/sfp037

M3 - Article

AN - SCOPUS:77955973922

SN - 1753-0784

VL - 2

SP - 292

EP - 294

JO - NDT Plus

JF - NDT Plus

IS - 4

ER -

Acute renal failure after treatment with sunitinib in a patient with multiple myeloma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this